Immunization

In a recent letter sent to President Biden, ASHP and more than 50 other health systems and provider organizations requested that the president activate federal resources to establish mass COVID-19 vaccination sites.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how COVID-19 vaccinations has affected the day-to-day of pharmacies.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on Walgreens’ plans to provide access to COVID-19 vaccines among vulnerable populations in medically underserved communities.

The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.

Moderna, Inc has also announced temporary authorization of its COVID-19 vaccine in Switzerland.

A recent study investigated the existence of “pharmacy deserts” in Los Angeles County in relation to the social determinants of health that show which communities have the greatest need for pharmacy access.

Soon, all Americans will be able to receive the vaccine at pharmacies including CVS and Walgreens, and their primary care provider's office.

Pharmacy Times® interviewed Alan Green, the US head of sales, infectious disease at AstraZeneca, on the Flu+Force campaign and the resources it provides to help pharmacists develop alternative flu vaccination sites.

The organization’s public statement comes after a pharmacist was arrested for destroying over 500 doses.

Pfizer and BioNTech, and Moderna have announced agreements to further supply vaccines against the coronavirus disease 2019 (COVID-19).

Earlier this month, the Canadian government also exercised its option to increase its confirmed order commitment of mRNA-1273.

This agreement brings the total number to be delivered to the United States to 200 million.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for managing the waiting period in the pharmacy following COVID-19 immunizations.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for immunizing staff at a hospital pharmacy with the COVID-19 vaccines.

Pharmacy Times® interviewed Michael Flannery, PharmD, of the University of Rochester Medical Center, on the process that the hospital pharmacy has developed for vaccinations following the arrival of the Pfizer and Moderna COVID-19 vaccines.

The announcement came hours after the companies disclosed that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion to authorize the vaccine.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the concerns he has regarding the COVID-19 vaccination process ahead.

The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.

The ACIP advises the CDC on the populations and circumstances for which vaccines should be used.

Moderna’s COVID-19 vaccine (mRNA-1273) has been granted Emergency Use Authorization (EUA) by the FDA, making it the second vaccine to be issued an EUA for combating the virus.

Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to engage diverse constituencies on the importance of the clinical trials process, regulatory review, and equitable access to COVID-19 vaccines.

The additional doses bring the EC’s confirmed order commitment to 160 million doses, which will commence from the company’s dedicated European supply chain.

Pharmacists can now play a larger role in increasing vaccination rates, while pharmacies can continue to be safe and convenient settings in which patients can receive vaccines.

If granted an EUA by the FDA, mRNA-1273 would become the second COVID-19 vaccine to receive the designation.

Pharmacy technicians are garnering support from key industry leaders as they rally for more active roles and responsibility.

A thorough understanding of immunization billing processes for Medicare, Medicaid, and other third-party payers will be critical to ensure pharmacy staff can efficiently serve their communities and facilitate a smooth reimbursement process.

Secretary Azar’s emergency declaration under PREP Act allows them to procure, dispense, and administer vaccinations once available.

If more patients are able to receive the vaccine through off-site vaccination clinics, the risk of influenza may be reduced even further.